Merck will purchase Phase II programs on the open market. They will not be creating them in house. Discovery as it was formerly understood is gone. It will be downsized to the point that it can function in the new model. For show and tell when there are visitors. Like floral bouquets in the lobby, but not as anything substantial. Merck is a smoke and mirror company. It will have smoke and mirror science, and take its chances with buying potential products from smaller players.
Merck has always shopped around for drugs, as do all pharma companies. It hasn't amounted to anything substantial that I can't think of. Internal R&D will make or break the company, like it or not. It is after all a science company.
Cuts are coming but I'm not as worried as senior management must be feeling. I doubt RP is impressed with all of their initiatives and SMART objectives of the last 5 years.
Merck has always shopped around for drugs, as do all pharma companies. It hasn't amounted to anything substantial that I can't think of. Internal R&D will make or break the company, like it or not. It is after all a science company./QUOTE]
Huh, I believe that Isentress was licensed in by Merck IRBM. Internal R&D hasn't produce anything significant since Januvia in 2004. Hence the current cut backs.
Merck has always shopped around for drugs, as do all pharma companies. It hasn't amounted to anything substantial that I can't think of. Internal R&D will make or break the company, like it or not. It is after all a science company.
Cuts are coming but I'm not as worried as senior management must be feeling. I doubt RP is impressed with all of their initiatives and SMART objectives of the last 5 years.
Still believe only marginal cut in 2013 in middle and upper mgt with deeper cuts coming 2014.
"...pain, a lot of pain...in the next few weeks..."
Roger Perlmutter
Damn we're stuck with RT. I guess basic R&D got their wish.
In his E-mail today, Rupert is heading Discovery and Rich Tillya still heading the Preclinical. All the franchises are gone. I was disappointed he didn't make more leadership changes, since we're not going to be able to get rid of the abusive low morale creating middle managers if he still has the same leadership on top. I was impressed with his talks though, and hope he has some real way of restoring dignity to the bench scientists as he talked about (before they all leave).what happened with rupert and rich tyller?
